• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . When fatigue and cognitive impairment persist- a neurological follow-up-study in patients with Post-COVID syndrome

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Nov 7;14(1):27083.
doi: 10.1038/s41598-024-78496-y. When fatigue and cognitive impairment persist- a neurological follow-up-study in patients with Post-COVID syndrome

Ann-Katrin Hennemann[SUP] 1 [/SUP], Melissa Timmermeister[SUP] 1 [/SUP], Nora Drick[SUP] 2 [/SUP], Isabell Pink[SUP] 2 [/SUP], Karin Weissenborn[SUP] 1 [/SUP], Meike Dirks[SUP] 3 [/SUP]



Affiliations
Abstract

Considering the relevance for patients, economics and public health data about the course of the neurological Post-COVID Syndrome (PCS) are urgently needed. In this study 94 PCS patients (73% female, age in median 49 years) were examined in median 9.4 (T1) and for a second time 14 months (T2) after mild to moderate SARS-CoV-2 infection. Mood, sleep quality and health related quality of life (QoL) were evaluated via structured anamnesis and self-report questionnaires; attention, concentration and memory via psychometric tests. 47% of the patients reported an improvement of their symptoms over time, but only 12% full recovery. 4% noticed deterioration and 49% no change. Main disturbances at both time points were fatigue, deficits in concentration and memory. In patients with perceived improvement QoL significantly increased between T1 and T2, although their test performance as well as the fatigue score remained unchanged. In patients with persisting impairment QoL, fatigue scores and psychometric test results did not change significantly. Abnormal psychometric tests were more frequent at both time points in the group without improvement. But, significant fatigue and cognitive impairment persisted for more than 1 year after SARS-CoV-2 infection in both groups.

Keywords: Cognitive impairment; Fatigue; Follow-up; Post-COVID syndrome.

 
Back
Top Bottom